Request Your Free White Paper Now:

"Puerto Rico on Gene & Cell Therapy: An Unparalleled Proposal for Non-Dilutive Funding"

Puerto Rico is becoming the best place in the world to conduct R&D activities for emerging technologies. Could your organization maximize growth potential by capitalizing on Puerto Rico’s unique tax incentives and culture of innovation?

Puerto Rico isn’t just a beach paradise, but a fast-growing hub for innovators who’ve made the island home as a start-up ecosystem has emerged.

Due to numerous tax credits and incentives for research and development, hosting world-class talent, and the availability of securing non-diluted financing, Puerto Rico is becoming a nesting place for emerging technology companies and clinical stage biotech and pharma companies. According to the Bureau of Labor Statistics, Puerto Rico led U.S. exports of pharmaceutical and medicine manufacturing in 2020, accounting for 19.3 percent of total U.S. exports.

In this whitepaper you will learn about:

• The value of non-dilutive funding for emerging companies
• Puerto Rico’s taxation policies that dramatically reduce costs and foster investment
• The stability and protections afforded to companies being located within a territory of the U.S.
• The growing community and culture of innovative business leaders, accelerators, and incubators.

Offered Free by: InvestPR
See All Resources from: InvestPR